Caris & Co. Upgrades ViroPharma (VPHM) to Above Average
Tweet Send to a FriendGet Alerts VPHM Hot Sheet
Price: $27.04 +2.27%
Rating Summary:
11 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
11 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade VPHM Now!
Earlier, Caris & Co. upgraded ViroPharma (NASDAQ: VPHM) from Average to Above Average with a price target of $30.00.
For an analyst ratings summary and ratings history on ViroPharma click here. For more ratings news on ViroPharma click here.
Shares of ViroPharma closed at $25.21 yesterday, with a 52 week range of $16.65-$33.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ViroPharma click here. For more ratings news on ViroPharma click here.
Shares of ViroPharma closed at $25.21 yesterday, with a 52 week range of $16.65-$33.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Topeka Capital Upgrades Pacific Sunwear of California (PSUN) to Buy
- Sidoti Upgrades Nordion Inc (NDZ) to Buy
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
